Ag-Desvenlafaxine 50 mg (Desvenlafaxine (Desvenlafaxine Succinate) TABLET (EXTENDED-RELEASE)) 50 MG

AG-DESVENLAFAXINE 50 MG is an extended-release tablet used to manage mood disorders. This medication, containing desvenlafaxine succinate, is designed for oral administration and is manufactured by Angita Pharma Inc. in Canada.

Strength

50 MG

Manufacturer / TM Owner

ANGITA PHARMA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

AG-DESVENLAFAXINE 50 MG is primarily used to help manage symptoms associated with mood disorders. Desvenlafaxine, the active ingredient, is often prescribed to support mental health. This medication is designed for long-term use and is intended to be taken as directed by a healthcare provider. It is important to follow the prescribed regimen for optimal results.

Side Effects

Common effects of AG-DESVENLAFAXINE 50 MG may include changes in mood, energy levels, and overall well-being. Some individuals may experience side effects such as nausea, dizziness, or fatigue. These effects can vary from person to person and may diminish over time as the body adjusts to the medication.

Precautions & Warnings

AG-DESVENLAFAXINE 50 MG should be handled with care and stored in a cool, dry place. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should not be shared with others, even if they have similar symptoms. Always consult a healthcare provider before making any changes to your medication regimen.

Avoid Interactions

AG-DESVENLAFAXINE 50 MG may interact with other medications, including those that affect the central nervous system. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs, supplements, and herbal products. Alcohol and certain foods may also interact with this medication, so it is advisable to discuss these with your healthcare provider.

Frequently Asked Questions

AG-DESVENLAFAXINE 50 MG is used to manage symptoms associated with mood disorders. It is designed for long-term use and should be taken as directed by a healthcare provider.

AG-DESVENLAFAXINE 50 MG is an extended-release tablet intended for oral administration. It should be taken exactly as prescribed by a healthcare professional.

Common side effects may include nausea, dizziness, and fatigue. These effects can vary and may diminish over time as the body adjusts to the medication.

AG-DESVENLAFAXINE 50 MG may interact with other medications, so it is important to inform your healthcare provider about all medications you are taking.

AG-DESVENLAFAXINE 50 MG is manufactured by Angita Pharma Inc. in Canada.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.